These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 15498441

  • 1. [Clinical and biochemical characteristics of familial ligand-defective apo B-100 in a South European population].
    Ejarque I, Real JT, Chaves FJ, Blesa S, González V, Milian E, Ascaso JF, Priego MA, Carmena R.
    Med Clin (Barc); 2004 Oct 09; 123(12):456-9. PubMed ID: 15498441
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of clinical diagnosis criteria of familial ligand defective apoB 100 and lipoprotein phenotype comparison between LDL receptor gene mutations affecting ligand-binding domain and the R3500Q mutation of the apoB gene in patients from a South European population.
    Ejarque I, Real JT, Martinez-Hervas S, Chaves FJ, Blesa S, Garcia-Garcia AB, Millan E, Ascaso JF, Carmena R.
    Transl Res; 2008 Mar 09; 151(3):162-7. PubMed ID: 18279815
    [Abstract] [Full Text] [Related]

  • 3. Differences in the phenotype between children with familial defective apolipoprotein B-100 and familial hypercholesterolemia.
    Pimstone SN, Defesche JC, Clee SM, Bakker HD, Hayden MR, Kastelein JJ.
    Arterioscler Thromb Vasc Biol; 1997 May 09; 17(5):826-33. PubMed ID: 9157944
    [Abstract] [Full Text] [Related]

  • 4. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK.
    Dan Med Bull; 2002 Nov 09; 49(4):318-45. PubMed ID: 12553167
    [Abstract] [Full Text] [Related]

  • 5. Differences in the phenotypic characteristics of subjects with familial defective apolipoprotein B-100 and familial hypercholesterolemia.
    Miserez AR, Keller U.
    Arterioscler Thromb Vasc Biol; 1995 Oct 09; 15(10):1719-29. PubMed ID: 7583549
    [Abstract] [Full Text] [Related]

  • 6. Familial defective apolipoprotein B-100.
    Hansen PS.
    Dan Med Bull; 1998 Sep 09; 45(4):370-82. PubMed ID: 9777289
    [Abstract] [Full Text] [Related]

  • 7. [Identification and characterization of the first Spanish familial ligand-defective apolipoprotein B homozygote].
    Ejarque I, Civer M, Francisco Ascaso J, Knecht E, Eugenia Armengod M, Carmen R, Tomás Real J, Francisco Chaves J, Javier Martín De Llano J.
    Med Clin (Barc); 2001 Feb 03; 116(4):138-41. PubMed ID: 11222161
    [Abstract] [Full Text] [Related]

  • 8. Phenotypic heterogeneity associated with defective apolipoprotein B-100 and occurrence of the familial hypercholesterolemia phenotype in the absence of an LDL-receptor defect within a Canadian kindred.
    Davignon J, Dufour R, Roy M, Bétard C, Ma Y, Ouellette S, Boulet L, Lussier-Cacan S.
    Eur J Epidemiol; 1992 May 03; 8 Suppl 1():10-7. PubMed ID: 1505645
    [Abstract] [Full Text] [Related]

  • 9. Influence of LDL receptor gene mutations and the R3500Q mutation of the apoB gene on lipoprotein phenotype of familial hypercholesterolemic patients from a South European population.
    Real JT, Chaves FJ, Ejarque I, García-García AB, Valldecabres C, Ascaso JF, Armengod ME, Carmena R.
    Eur J Hum Genet; 2003 Dec 03; 11(12):959-65. PubMed ID: 14508510
    [Abstract] [Full Text] [Related]

  • 10. [Plasma lipoprotein (a) values in familial defective ligand apo B 100 in a South European population].
    Ejarque I, Leal JT, Ascaso JF, Chaves FJ, Milian E, Priego MA, Carmena R.
    An Med Interna; 2004 Jul 03; 21(7):322-5. PubMed ID: 15347236
    [Abstract] [Full Text] [Related]

  • 11. Compound heterozygous familial hypercholesterolemia and familial defective apolipoprotein B-100 produce exaggerated hypercholesterolemia.
    Tai ES, Koay ES, Chan E, Seng TJ, Loh LM, Sethi SK, Tan CE.
    Clin Chem; 2001 Mar 03; 47(3):438-43. PubMed ID: 11238294
    [Abstract] [Full Text] [Related]

  • 12. Familial defective apolipoprotein B-100 in Slovakia: are differences in prevalence of familial defective apolipoprotein B-100 explained by ethnicity?
    Gasparovic J, Basistová Z, Fábryová L, Wsólová L, Vohnout B, Raslová K, Slovak MED PED FH group.
    Atherosclerosis; 2007 Oct 03; 194(2):e95-107. PubMed ID: 17194460
    [Abstract] [Full Text] [Related]

  • 13. Familial defective apolipoprotein B-100: a lesson from homozygous and heterozygous patients.
    Ceska R, Vrablík M, Horínek A.
    Physiol Res; 2000 Oct 03; 49 Suppl 1():S125-30. PubMed ID: 10984082
    [Abstract] [Full Text] [Related]

  • 14. Statin therapy in a kindred with both apolipoprotein B and low density lipoprotein receptor gene defects.
    Raal FJ, Pilcher G, Rubinsztein DC, Lingenhel A, Utermann G.
    Atherosclerosis; 1997 Feb 28; 129(1):97-102. PubMed ID: 9069523
    [Abstract] [Full Text] [Related]

  • 15. Clinical signs of familial hypercholesterolemia in patients with familial defective apolipoprotein B-100 and normal low density lipoprotein receptor function.
    Myant NB, Gallagher JJ, Knight BL, McCarthy SN, Frostegård J, Nilsson J, Hamsten A, Talmud P, Humphries SE.
    Arterioscler Thromb; 1991 Feb 28; 11(3):691-703. PubMed ID: 1674216
    [Abstract] [Full Text] [Related]

  • 16. Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolaemia.
    Myant NB.
    Atherosclerosis; 1993 Dec 28; 104(1-2):1-18. PubMed ID: 8141833
    [Abstract] [Full Text] [Related]

  • 17. Characterization of six patients who are double heterozygotes for familial hypercholesterolemia and familial defective apo B-100.
    Rubinsztein DC, Raal FJ, Seftel HC, Pilcher G, Coetzee GA, van der Westhuyzen DR.
    Arterioscler Thromb; 1993 Jul 28; 13(7):1076-81. PubMed ID: 8318509
    [Abstract] [Full Text] [Related]

  • 18. Familial defective apolipoprotein B versus familial hypercholesterolemia: an assessment of risk.
    Fouchier SW, Defesche JC, Kastelein JJ, Sijbrands EJ.
    Semin Vasc Med; 2004 Aug 28; 4(3):259-64. PubMed ID: 15630635
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Serum low density lipoprotein cholesterol level and cholesterol absorption efficiency are influenced by apolipoprotein B and E polymorphism and by the FH-Helsinki mutation of the low density lipoprotein receptor gene in familial hypercholesterolemia.
    Gylling H, Aalto-Setälä K, Kontula K, Miettinen TA.
    Arterioscler Thromb; 1991 Aug 28; 11(5):1368-75. PubMed ID: 1911722
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.